Tag: Autoimmunity

Affecting an estimated 15,000 to 30,000 people annually in the United States, drug-induced lupus (DIL) is an autoimmune-like syndrome triggered by exposure to certain medications. While the list of potentially causative agents is extensive and constantly evolving with new treatments, definitive links exist for many common drugs. Understanding what causes drug-induced lupus is crucial for both healthcare providers and patients to facilitate early diagnosis and intervention.

An estimated 15,000–30,000 cases of drug-induced lupus occur annually in the U.S., making it a known, though rare, complication of certain medications. Understanding **what blood pressure medications trigger lupus** is vital for patients and clinicians alike, as early recognition is key for proper management.

Affecting an estimated 1 in 100 people worldwide, celiac disease remains a significant health challenge, with the gluten-free diet as the only current treatment. While there is no single new pill for celiac disease currently approved, an exciting pipeline of investigational oral medications is advancing through clinical trials, offering hope beyond dietary restrictions.

With a significant presence in the biopharmaceutical industry, Incyte has developed a diverse portfolio of treatments aimed at areas of high unmet medical need, particularly oncology, inflammation, and dermatology. Understanding what drugs does Incyte make involves exploring their proprietary therapies as well as co-marketed and licensed products.

Up to 15% of completely healthy people have a positive antinuclear antibody (ANA) test, but certain drugs can also trigger this result [1.4.1]. Understanding what medications can give you a positive ANA is crucial for accurate diagnosis and avoiding unnecessary concern.

Doxycycline is one of the most commonly prescribed antibiotics in the US, with over 5 million prescriptions annually, yet cases suggesting a link to vasculitis are exceedingly rare. Though vasculitis can be triggered by medications, the connection between **doxycycline and vasculitis** is not well-established and primarily documented through isolated case reports, not large-scale studies.

Only about 2 to 3 per 100,000 individuals taking statin medications develop the rare autoimmune condition known as statin-associated autoimmune myopathy (SAAM). This article explores what autoimmune disease is caused by statins, detailing its characteristics, diagnosis, and management options for this specific complication.

For some conditions, Intravenous Immunoglobulin (IVIG) therapy can lead to significant and sustained improvement after a single dose. However, the notion that IVIG is a one-time treatment is a common misconception, as most people require multiple infusions over an extended period.

According to preclinical studies and initial clinical data, ARGX-117, now known as empasiprubart, can reduce free circulating C2 levels by up to 99%. This powerful effect is key to understanding what is the mechanism of action of argx 117, a novel therapeutic strategy for treating complement-mediated autoimmune diseases.

While infections are a known trigger for autoimmune conditions, the notion that vaccines can also cause autoimmunity has been thoroughly examined. Although the flu shot is extremely safe for most people, some studies have shown a very small increased risk of a rare autoimmune disease called Guillain-Barre Syndrome (GBS).